Michael Cross

Michael Cross

Corporate Officer/Principal chez SATELLOS BIOSCIENCE INC.
61 ans
Health Technology
Finance
Consumer Services

Profil

Michael B. Cross is the founder of ARTMS, Inc. Dr. Cross is currently Director at AdipoGenix, Inc., Director at Aegera Therapeutics, Inc., Director at Praxim SA, and Chief Business Officer at Satellos Bioscience, Inc. Formerly, Dr. Cross was Director at Agrisoma Biosciences, Inc., Director at Trillium Therapeutics, Inc. from 2000 to 2012, Director at Viron Therapeutics, Inc., Principal at Nordion (Canada), Inc. from 1996 to 2003, Chief Business Officer at OncoSec Medical, Inc. in 2012, Manager-Investments at Lumira Capital Investment Management, Inc., Senior Vice President & Portfolio Manager at Fairway Capital Management Corp., Principal at TraumaTec, Inc., and Principal at Canada Department of National Defence (Canada).
Dr. Cross earned an MBA and a doctorate from the University of Toronto.

Postes actifs de Michael Cross

SociétésPosteDébut
SATELLOS BIOSCIENCE INC. Corporate Officer/Principal 01/09/2023
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 24/09/2009
Directeur/Membre du Conseil 22/10/2009
Fondateur -

Anciens postes connus de Michael Cross

SociétésPosteFin
Directeur/Membre du Conseil -
ONCOSEC MEDICAL INCORPORATED Directeur des opérations 12/03/2012
Corporate Officer/Principal 04/09/2008
NORDION INC Corporate Officer/Principal 01/01/2003
░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de Michael Cross

Formation de Michael Cross

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

62

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées15

Health Technology

Health Technology

Health Technology

Finance

Finance

Consumer Services

Process Industries

Health Technology

Commercial Services

Health Technology

Health Technology

Electronic Technology

Government

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Michael Cross
🔇